NCT04244890View on ClinicalTrials.gov

Feasibility of Uninterrupted Infant Respiratory Support Treatment

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

February 21, 2020

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
Respiratory Distress Syndrome, NewbornInfant, NewbornRespiratory Insufficiency Syndrome of Newborn
Interventions
DEVICE

Uninterrupted CPAP for the first hours of life

Directly at birth the infant will be supported with PPV with PEEP as needed, followed by nasal CPAP. Support will be provided with a single device for up to four hours.

Trial Locations (1)

171 76

Karolinska University Hospital, Neonatology department, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT04244890 - Feasibility of Uninterrupted Infant Respiratory Support Treatment | Biotech Hunter | Biotech Hunter